Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Pharmagreen Biotech's operating assets for the quarter that ended in Jun. 2023 was $0.14 Mil. Pharmagreen Biotech's operating liabilities for the quarter that ended in Jun. 2023 was $1.89 Mil. Pharmagreen Biotech's Total Assets for the quarter that ended in Mar. 2023 was $0.16 Mil. Therefore, Pharmagreen Biotech's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was -10.77.
Pharmagreen Biotech Scaled Net Operating Assets Related Terms
Pharmagreen Biotech Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Pharmagreen Biotech's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmagreen Biotech Scaled Net Operating Assets Chart
PHBI vs DVLP, CSTF, BLMS: Scaled Net Operating Assets Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmagreen Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmagreen Biotech Scaled Net Operating Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmagreen Biotech's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Pharmagreen Biotech's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of -10.77 mean?
Pharmagreen Biotech (PHBI) has a Scaled Net Operating Assets of -10.77 as of Jun. 2023. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Pharmagreen Biotech and its competitors.
Is Pharmagreen Biotech's Scaled Net Operating Assets too high?
Pharmagreen Biotech's current Scaled Net Operating Assets is -10.77.
How does Pharmagreen Biotech's Scaled Net Operating Assets compare to DVLP and CSTF?
Pharmagreen Biotech's Scaled Net Operating Assets of -10.77 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Pharmagreen Biotech and its competitors. Pharmagreen Biotech's current Scaled Net Operating Assets is -10.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmagreen Biotech stock overvalued right now?
Pharmagreen Biotech (PHBI) has a current Scaled Net Operating Assets of -10.77. The current Scaled Net Operating Assets is -10.77. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Pharmagreen Biotech (PHBI), the current Scaled Net Operating Assets is -10.77 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHBI has been successfully added to your 